NADAC acquisition cost data for NO DRIP 0.05% NASAL SPRAY. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 24385035210 | $0.0578 | 2022-12-21 | OTC |
| 24385035210 | $0.0578 | 2022-12-21 | OTC |
Generic: Desmopressin Acetate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | 897 | N/A |
| 2020 | N/A | N/A | 861 | N/A |
| 2021 | N/A | N/A | 901 | N/A |
| 2022 | $2.1M | 2,850 | 907 | $16.78 |
| 2023 | $2.0M | 2,686 | 643 | $16.89 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $283.4K | 386 | 91 |
| New Jersey | $207.9K | 286 | 60 |
| Florida | $156.4K | 206 | 52 |
| Texas | $129.4K | 161 | 55 |
| New York | $117.2K | 174 | 45 |
| Pennsylvania | $98.2K | 153 | 24 |
| Michigan | $86.2K | 110 | 24 |
| Illinois | $67.3K | 84 | 26 |
| Georgia | $63.0K | 70 | 21 |
| Maryland | $58.2K | 67 | 19 |
| South Carolina | $58.0K | 81 | 17 |
| Colorado | $57.9K | 86 | 26 |
| Ohio | $54.1K | 70 | 18 |
| Arizona | $51.7K | 60 | 15 |
| North Carolina | $46.6K | 67 | 13 |
| Massachusetts | $44.3K | 51 | 12 |
| Washington | $42.5K | 42 | 11 |
| Indiana | $37.5K | 45 | N/A |
| Alabama | $37.4K | 56 | 11 |
| Tennessee | $37.3K | 52 | 12 |
| Virginia | $35.8K | 35 | N/A |
| Louisiana | $35.0K | 65 | N/A |
| Kansas | $27.3K | 47 | N/A |
| Missouri | $24.9K | 39 | 11 |
| Oklahoma | $20.1K | 27 | N/A |
| New Hampshire | $18.2K | 14 | N/A |
| Wisconsin | $17.4K | 28 | N/A |
| Vermont | $16.0K | 13 | N/A |
| Connecticut | $15.3K | 23 | N/A |
| Nebraska | $12.8K | 19 | N/A |
| Kentucky | $9.6K | 18 | N/A |
| Iowa | $9.2K | 18 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.